Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | FASN | P49327 | 1/20 | 0.52 |
| ▸ | FAAH | O00519 | 5/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.43 |
| ▸ | CNR1 | P21554 | 2/20 | 0.41 |
| ▸ | CNR2 | P34972 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11075388 | 1.00 | ALDH1A1 (0.60) | ALDH1A1TSHRFASNFAAHTRPV1 | |
| SCHEMBL28857029 | 1.00 | ALDH1A1 (0.60) | ALDH1A1TSHRFASNFAAHTRPV1 | |
| SCHEMBL732262 | 1.00 | ALDH1A1 (0.60) | ALDH1A1TSHRFASNFAAHTRPV1 | |
| SCHEMBL11299875 | 1.00 | ALDH1A1 (0.60) | ALDH1A1TSHRFASNFAAHTRPV1 | |
| SCHEMBL1732905 | 1.00 | ALDH1A1 (0.60) | ALDH1A1TSHRFASNFAAHTRPV1 | |
| SCHEMBL2277623 | 0.97 | TSHR (0.58) | ALDH1A1TSHRFASNFAAHTRPV1 | |
| SCHEMBL20610573 | 0.97 | TSHR (0.58) | ALDH1A1TSHRFASNFAAHTRPV1 | |
| SCHEMBL21122035 | 0.97 | TSHR (0.58) | ALDH1A1TSHRFASNFAAHTRPV1 | |
| SCHEMBL2915027 | 0.97 | ALDH1A1 (0.64) | ALDH1A1TSHRFASNFAAHTRPV1 | |
| SCHEMBL2275976 | 0.97 | TSHR (0.58) | ALDH1A1TSHRFASNFAAHTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 275 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2239299-B1 | THERMOPLASTIC ELASTOMER COMPOSITION AND METHOD FOR PRODUCING THE SAME | ASAHI KASEI CHEMICALS CORP (JP) | 2014-06-11 | — | — | EP | claimed |
| EP-2173922-A1 | RUTHENIUM PRECURSOR WITH TWO DIFFERING LIGANDS FOR USE IN SEMICONDUCTOR APPLICATIONS | L'Air Liquide Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude (FR) | 2010-04-14 | — | — | EP | claimed |
| US-20090028745-A1 | RUTHENIUM PRECURSOR WITH TWO DIFFERING LIGANDS FOR USE IN SEMICONDUCTOR APPLICATIONS | L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) | 2009-01-29 | — | — | US | claimed |
| WO-2009013721-A1 | RUTHENIUM PRECURSOR WITH TWO DIFFERING LIGANDS FOR USE IN SEMICONDUCTOR APPLICATIONS | L'AIR LIQUIDE-SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (US) | 2009-01-29 | — | — | WO | claimed |
| US-6720468-B2 | BY REACTING WITH A DIELS-ALDER DIENOPHILE TO PROVIDE A FLUID COMPRISING A DIELS-ALDER ADDUCT AND MONOOLEFINS; AND RECOVERING A RESULTING MONOOLEFIN-CONTAINING FLUID | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2004-04-13 | — | — | US | claimed |
| US-20020165420-A1 | Process for the removal of conjugated olefins from a monoolefin stream | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2002-11-07 | — | — | US | claimed |
| EP-1220655-A1 | COMPOSITIONS CONTAINING COPOLYMERS OF ISOPRENE, BUTADIENE AND/OR STYRENE FOR USE IN HUMAN SKIN CARE AND HAIR CARE | EXXONMOBIL OIL CORPORATION (US) | 2002-07-10 | — | — | EP | claimed |
| US-20020002255-A1 | Ethylene polymers with alpha-olefins | SOCIETA' ITALIANA ADDITIVI PERCARBURANTI S.R.L. | 2002-01-03 | — | — | US | claimed |
| US-6278032-B1 | MIXING MIDDLE DISTILLATES WITH ETHYLENE-OCTENE CO-POLYMERS AND TERPOLYMERS COMPRISING ETHYLENE, OCTENE WITH ALPHA-OLEFIN AND MONOMERS CONTAINING MORE THAN ONE ETHYLENIC UNSATURATION FOR IMPROVING COLD FLOW PROPERTIES | SOCIETA' ITALIANA ADDITIVI PER CARBURANTI S.R.L. (IT) | 2001-08-21 | — | — | US | claimed |
| WO-2001026620-A1 | COMPOSITIONS CONTAINING COPOLYMERS OF ISOPRENE, BUTADIENE AND/OR STYRENE FOR USE IN HUMAN SKIN CARE AND HAIR CARE | MOBIL OIL CORPORATION (US) | 2001-04-19 | — | — | WO | claimed |
| EP-0677065-A1 | EPOXIDIZED BLOCK COPOLYMERS. | EASTMAN CHEM CO (US) | 1995-10-18 | — | — | EP | claimed |
| US-5457161-A | Preferential hydrogenation | MOBIL OIL CORPORATION (US) | 1995-10-10 | — | — | US | claimed |
| US-5376722-A | Formed of different conjugated dienes selectively hydrogenated | MOBIL OIL CORPORATION (US) | 1994-12-27 | — | — | US | claimed |
| WO-1994015973-A2 | EPOXIDIZED BLOCK COPOLYMERS | EASTMAN CHEMICAL COMPANY (US) | 1994-07-21 | — | — | WO | claimed |
| US-5306780-A | Selectively hydrogenated | MOBIL OIL CORPORATION (US) | 1994-04-26 | — | — | US | claimed |
| US-5268427-A | Containing conjugated diene | MOBIL OIL CORPORATION (US) | 1993-12-07 | — | — | US | claimed |
| US-5187236-A | High elongation, good aging properties | MOBIL OIL CORPORATION (US) | 1993-02-16 | — | — | US | claimed |
| US-5149895-A | Selectively Hydrogenated Conjugated Diene Block Polymer | MOBIL OIL CORPORATION (US) | 1992-09-22 | — | — | US | claimed |
| EP-0441485-A2 | Vulcanizable liquid copolymer | MOBIL OIL CORPORATION (US) | 1991-08-14 | — | — | EP | claimed |
| EP-0438287-A2 | Solid block and random elastomeric copolymers | MOBIL OIL CORPORATION (US) | 1991-07-24 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020165420-A1 | Process for the removal of conjugated olefins from a monoolefin stream | ADH1C, ADH1A, OXER1 | ALDH1A1 58/4885TSHR 4613/4885FASN 241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.